<DOC>
	<DOCNO>NCT00097877</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The purpose study test whether Biphasic Insulin Aspart 70/30 twice day Metformin improve glycemic control vs. daily Insulin Glargine Metformin subject Type 2 Diabetes inadequately control basal insulin plus oral anti-diabetic therapy .</brief_summary>
	<brief_title>Comparison Biphasic Insulin Aspart 70/30 Versus Insulin Glargine Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 2 Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Type 2 Diabetes</keyword>
</DOC>